FI924035A0 - NYA 5-AMINO-4-HYDROXYHEXANSYRADERIVES SAOSOM THERAPEUTIC MEDEL. - Google Patents

NYA 5-AMINO-4-HYDROXYHEXANSYRADERIVES SAOSOM THERAPEUTIC MEDEL.

Info

Publication number
FI924035A0
FI924035A0 FI924035A FI924035A FI924035A0 FI 924035 A0 FI924035 A0 FI 924035A0 FI 924035 A FI924035 A FI 924035A FI 924035 A FI924035 A FI 924035A FI 924035 A0 FI924035 A0 FI 924035A0
Authority
FI
Finland
Prior art keywords
hydroxyhexansyraderives
saosom
medel
nya
therapeutic
Prior art date
Application number
FI924035A
Other languages
Finnish (fi)
Other versions
FI924035A (en
Inventor
Marc Lang
Guido Bold
Alexander Faessler
Peter Schneider
Hoogevest Peter Van
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI924035A0 publication Critical patent/FI924035A0/en
Publication of FI924035A publication Critical patent/FI924035A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FI924035A 1991-09-12 1992-09-09 NYA 5-AMINO-4-HYDROXYHEXANSYRADERIVES SAOSOM THERAPEUTIC MEDEL FI924035A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH268991 1991-09-12
CH98092 1992-03-27
CH200792 1992-06-25

Publications (2)

Publication Number Publication Date
FI924035A0 true FI924035A0 (en) 1992-09-09
FI924035A FI924035A (en) 1993-03-13

Family

ID=27172572

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924035A FI924035A (en) 1991-09-12 1992-09-09 NYA 5-AMINO-4-HYDROXYHEXANSYRADERIVES SAOSOM THERAPEUTIC MEDEL

Country Status (15)

Country Link
EP (1) EP0532466A3 (en)
JP (1) JPH05230095A (en)
KR (1) KR930006050A (en)
AU (1) AU661018B2 (en)
CA (1) CA2077948A1 (en)
CZ (1) CZ280292A3 (en)
FI (1) FI924035A (en)
HU (1) HUT63632A (en)
IL (1) IL103126A (en)
MX (1) MX9205208A (en)
NO (1) NO923533L (en)
NZ (1) NZ244288A (en)
PL (1) PL169969B1 (en)
RU (1) RU2067585C1 (en)
SK (1) SK280292A3 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643878A (en) * 1991-09-12 1997-07-01 Ciba-Geigy Corporation 5-amino-4-hydroxyhexanoic acid derivatives
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
BR9306058A (en) * 1992-03-11 1997-11-18 Narhex Ltd Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
MXPA93002392A (en) 1992-03-11 2005-02-04 Narhex Ltd Amine derivatives of oxo- and hydroxy-substitued hydrocarbons.
TW217410B (en) * 1992-04-01 1993-12-11 Ciba Geigy
DE59303870D1 (en) 1992-12-23 1996-10-24 Ciba Geigy Ag Antiretroviral hydrazine derivatives
EP0618222A3 (en) * 1993-03-11 1997-01-02 Ciba Geigy Ag Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid.
EP0626178A1 (en) * 1993-05-17 1994-11-30 Ciba-Geigy Ag Use of inhibitors of HIV-protease for the treatment of tumorous diseases
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
IL110752A (en) * 1993-09-13 2000-07-26 Abbott Lab Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
US5559158A (en) * 1993-10-01 1996-09-24 Abbott Laboratories Pharmaceutical composition
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
WO1996016980A1 (en) * 1994-11-29 1996-06-06 Novartis Ag Morpholinoethylamide derivatives
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
AU7475396A (en) * 1995-10-30 1997-05-22 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
US5840835A (en) * 1995-10-30 1998-11-24 Merck & Co., Inc. Inhibitors of peptide binding to MHC class II proteins
US5817757A (en) * 1995-10-30 1998-10-06 Merck & Co., Inc. Inhibitors of peptide binding to MHO class II proteins
US5914332A (en) 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
US6232333B1 (en) 1996-11-21 2001-05-15 Abbott Laboratories Pharmaceutical composition
CZ20012714A3 (en) * 1999-01-28 2002-08-14 Chugai Seiyaku Kabushiki Kaisha Substituted phenetylamine derivatives
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
KR100708221B1 (en) 1999-08-31 2007-04-17 아지노모토 가부시키가이샤 Method for producing epoxide crystal
CA2395987C (en) 2000-01-19 2009-12-22 Abbott Laboratories Improved pharmaceutical formulations
US6506786B2 (en) 2001-02-13 2003-01-14 Pharmacor Inc. HIV protease inhibitors based on amino acid derivatives
UA79834C2 (en) * 2002-11-01 2007-07-25 Viropharma Inc Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
ES2452718T3 (en) 2005-11-30 2014-04-02 Taimed Biologics, Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
CN103382216B (en) 2006-01-27 2016-04-20 菲布罗根有限公司 Make the Cyanoisoquinoline compound that hypoxia inducible factor (HIF) is stable
WO2007115315A2 (en) 2006-04-04 2007-10-11 Fibrogen, Inc. Pyrrolo- and thiazolo-pyridine compounds as hif modulators
CA2664118A1 (en) 2006-09-21 2008-07-03 Ambrilia Biopharma Inc. Protease inhibitors
EP2370422B1 (en) 2008-11-14 2019-06-05 Fibrogen, Inc. Thiochromene derivatives as hif hydroxylase inhibitors
TWI685487B (en) 2013-01-24 2020-02-21 美商費比羅根公司 Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126326A (en) * 1989-06-06 1992-06-30 Bio-Mega, Inc. Enzyme inhibiting peptide derivatives

Also Published As

Publication number Publication date
IL103126A (en) 1997-09-30
EP0532466A3 (en) 1993-06-16
KR930006050A (en) 1993-04-20
FI924035A (en) 1993-03-13
HUT63632A (en) 1993-09-28
RU2067585C1 (en) 1996-10-10
IL103126A0 (en) 1993-02-21
NZ244288A (en) 1995-03-28
AU661018B2 (en) 1995-07-13
EP0532466A2 (en) 1993-03-17
PL295905A1 (en) 1993-05-17
HU9202925D0 (en) 1992-11-30
NO923533D0 (en) 1992-09-11
MX9205208A (en) 1993-03-01
CZ280292A3 (en) 1994-01-19
PL169969B1 (en) 1996-09-30
CA2077948A1 (en) 1993-03-13
AU2288992A (en) 1993-03-18
NO923533L (en) 1993-03-15
SK280292A3 (en) 1995-02-08
JPH05230095A (en) 1993-09-07

Similar Documents

Publication Publication Date Title
FI924035A0 (en) NYA 5-AMINO-4-HYDROXYHEXANSYRADERIVES SAOSOM THERAPEUTIC MEDEL.
FI924077A0 (en) NYA OMAETTADE ACYKLISKA PURIN- OCH PYRIMIDINPHOSPHONATDERIVAT.
FI921135A0 (en) NYA CARBONSYRAMIDE.
FI924557A0 (en) NYA PHENYLPYRAZOLFUNGICIDER
FI920279A (en) NYA SULFONYLUREA-FOERENINGAR.
FI933451A (en) NYA STEROIDESTRAR
FI933450A (en) NYA STEROIDER
FI934203A (en) NYA ACTIVE FOERENINGAR
FI922238A0 (en) STOED FOER THERAPEUTIC MAGNET.
FI921614A0 (en) NYA HERBICIDER.
FI925086A0 (en) NYA HYBRID-VAEXTFAKTORER
FI924353A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA ACYLALER AV IMIDAZOLE-5-CARBOXYLSYRADERIVAT.
FI923872A0 (en) NYA BENSOPYRANDERIVAT.
FI922552A0 (en) NYA KEFEMFOERENINGAR.
FI910208A0 (en) FUNGICIDA MEDEL.
FI923355A0 (en) VAETSKEFORMIGT HUSHAOLLSTVAETTMEDEL INNEHAOLLANDE INSEKT REPELLERANDE MEDEL.
FI925722A (en) NYA TIAZOLER
FI922425A0 (en) NYA 14-KRON-4-ETERDERIVAT.
FI920701A0 (en) ANORDNING FOER THERAPEUTIC TRYCK- BEHANDLING.
FI912644A0 (en) ANTIMICROBISC MEDICINE.
FI925679A0 (en) NYA IMIDAZOLER
FI910753A0 (en) THERAPEUTIC NUCLEOCIDER.
FI923674A0 (en) NYA HERBICIDER.
FI920878A (en) NYA TETRAHYDROFURANMELLANPRODUKTER
FI915521A0 (en) MEDEL FOER RENGOERING AV TEXTILER.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed